Simvastatin as add-on therapy to interferon β-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Præsentation
Citationsformater

Sørensen, Per Soelberg
Jan Lycke
Juha-Pekka Erälinna
Astrid Edland
Xingchen Wu
Jette Lautrup Frederiksen
Annette Oturai
Clas Malmeström
Egon Stenager
Sellebjerg, Finn Thorup
Helle Bach Sondergaard
SIMCOMBIN study investigators

Treatment of relapsing-remitting multiple sclerosis with interferon beta is only partly effective. We aimed to establish whether add-on of simvastatin, a statin with anti-inflammatory properties, improves this efficacy.

Originalsprog	Engelsk
Tidsskrift	Lancet Neurology
Vol/bind	10
Udgave nummer	8
Sider (fra-til)	691-701
Antal sider	11
ISSN	1474-4422
DOI	https://doi.org/10.1016/S1474-4422(11)70144-2
Status	Udgivet - 2011

ID: 40194325